Elevra Lithium Limited · ASX:ELV

Elevra Lithium — Shareholder Meeting (November 2026)

32 slides from Elevra Lithium's shareholder meeting presentation, Nov 19, 2026

  1. Slide 1: 2026 Annual General Meeting Chair Address and MD/CEO Presentation

    ASX ANNOUNCEMENT 19 November 2026 For personal use only 2026 Annual General Meeting Chair Address and MD/CEO Presentation Good morning ladies and gentlemen, shareholders, and esteemed guests. My name is Dawne Hickton, the Chair of Elevra Lithium Limited. On behalf of my fellow Directors, it is my pl

  2. Slide 2: Chair Address (continued)

    schedule rather than pacing our investment around future financing events. It also funds the technical and pre-development work at Moblan through to a Final Investment Decision. At Moblan, we took another step forward there. We acquired the offtake rights over Moblan that had been granted to a third

  3. Slide 3: Chair Address (continued) and About Elevra Lithium

    exercise objective judgement, challenge management constructively, and act in the interests of all shareholders. Second, we wanted to keep the right mix of skills and diversity of experience at the table. We need directors with operating, technical, financial and capital markets experience, along wit

  4. Slide 4: Elevra Lithium 2026 Annual General Meeting

    rsonal use only Elevra Lithium 2026 Annual General Meeting Thursday, 19 November 2026 ASX:ELV • NASDAQ:ELVR

  5. Slide 5: 2026 AGM Agenda

    2026 AGM Agenda rsonal use only 01 Chair’s Address 02 Meeting Procedures 03 Resolutions, Proxies and Voting 04 Managing Director & CEO Presentation 05 Questions ELEVRA LITHIUM 2

  6. Slide 6: Chair's Address

    rsonal use only 01 Chair’s Address Dawne Hickton

  7. Slide 7: FY26 Strategic Accomplishments

    FY26 Strategic Accomplishments Resetting the corporate foundation Advancing the project pipeline rsonal use only Merger completed1 NAL Brownfield Expansion scoping complete5 Completed the merger between Sayona Mining and Piedmont Lithium, Evaluated expansion opportunities and completed Scoping Studi

  8. Slide 8: Portfolio Optimisation

    Portfolio Optimisation Divesting non-core assets to concentrate on North American development rsonal use only US$71m A$16m 4 Ewoyaa sale completed1 Tabba Tabba tenement sold2 WA projects proposed for the Morella Lithium JV3 Outcome Consideration from Wildcat Proposed terms (non-binding) • Sold all r

  9. Slide 9: Board of Directors

    Board of Directors A Majority Independent and Diverse Board Board of Directors Current Post 2026 AGM1 rsonal use only Independence 25% 33% Independent > 67% Non-Independent 75% Dawne Hickton Lucas Dow James Brown Christina Alvord Chair & Non-Exec. Director Managing Director & CEO Non-Executive Direc

  10. Slide 10: Meeting Procedures

    rsonal use only 02 Meeting Procedures

  11. Slide 11: How to ask a question

    How to ask a question rsonal use only • To ask a question, select the “Q&A” icon • Select the topic of your question related to from the drop-down list • Type your question in the text box and press the “send” button • To ask a verbal question, follow the instructions below the broadcast window ELEV

  12. Slide 12: How to vote

    How to vote rsonal use only • When the poll is open, select the “Vote” icon at the top of the screen • To vote, select either “For”, “Against” or “Abstain” • You will see a vote confirmation • To change or cancel your vote, “Click here to change your vote” at any time until the poll is closed ELEVRA

  13. Slide 13: Resolutions, Proxies and Voting

    rsonal use only 03 Resolutions, Proxies and Voting

  14. Slide 14: Adoption of Remuneration Report

    Resolution 1 Adoption of Remuneration Report rsonal use only To consider and, if thought fit, pass the following non-binding resolution as an ordinary resolution: “That, for the purposes of section 250R(2) of the Corporations Act, the Remuneration Report for the year ended 30 June 2026 is adopted.”

  15. Slide 15: Re-election of Director – James Brown

    Resolution 2 Re-election of Director – James Brown rsonal use only To consider and, if thought fit, pass the following resolution as an ordinary resolution: “That Mr. James Brown who retires by rotation in accordance with rule 7.1(d) of the Constitution and ASX Listing Rule 14.4, and being eligible,

  16. Slide 16: Grant of STI Performance Rights to the MD and CEO

    Resolution 3 Grant of STI Performance Rights to the Managing Director and CEO rsonal use only To consider and, if thought fit, pass the following resolution as an ordinary resolution: “That approval be given for all purposes, including ASX Listing Rule 10.14, for the grant of 56,558 STI Performance

  17. Slide 17: Grant of LTI Performance Rights to the MD and CEO

    Resolution 4 Grant of LTI Performance Rights to the Managing Director and CEO rsonal use only To consider and, if thought fit, pass the following resolution as an ordinary resolution: “That approval be given for all purposes, including ASX Listing Rule 10.14, for the grant of 140,050 LTI Performance

  18. Slide 18: Managing Director & CEO Presentation

    rsonal use only 04 Managing Director & CEO Presentation Lucas Dow

  19. Slide 19: FY26 Highlights

    FY26 Highlights FY26 strengthened NAL’s operating platform, improved safety and operational resilience, and established the foundation for a fully funded expansion rsonal use only Operations Financial Corporate 197,967 $202M Merger between • Dual listed on ASX and Nasdaq with ability to convert hold

  20. Slide 20: The Elevra Strategy

    The Elevra Strategy Disciplined delivery remains central to our strategy rsonal use only 01 02 03 Optimise Existing Operations Develop Assets Following Integrate into the Supply Chain Expanded Resource Base Via Strategic Partnerships Focused on optimising production sustainably Deliver portfolio pot

  21. Slide 21: Commercial Strategy

    Commercial Strategy Targeting a diversified, market-linked and flexible sales portfolio as NAL volumes expand 01 Strategic Offtake 02 Market-Based Pricing 03 Commercial rsonal use only Partnerships Framework Flexibility • Targeting 2-3 core offtake customers • Spot-linked pricing using recognised •

  22. Slide 22: FY26 Health and Safety Performance

    FY26 Health and Safety Performance Safety performance materially improved, reinforcing a strong operating culture Safety performance strengthened alongside rsonal use only increased operational activity, providing a stronger TRIFR Per Million Work Hours1,2 foundation for the NAL expansion • Signific

  23. Slide 23: Operational Performance

    Operational Performance Resilient operating performance despite temporary mining constraints rsonal use only Delivering within revised FY26 guidance NAL Production & Unit Operating Costs 100,000 FY26 FY26 FY26 UOM Guidance Guidance Actual 1,000 (revised)1 (initial)1 90,000 894 907 Production Metrics

  24. Slide 24: Strategic Financing Package

    Strategic Financing Package Secured funding to accelerate near-term growth and advance growth initiatives1 rsonal use only Accelerating NAL Funding Certainty Enhanced Balance Sheet Continued Focus on Expansion Delivery Flexibility Growth Initiatives • Brings forward incremental • Timely funding cert

  25. Slide 25: NAL Expansion Transforms Elevra into a Larger, Lower Cost Producer

    NAL Expansion Transforms Elevra into a Larger, Lower Cost Producer Expanded output and lower unit costs create a pathway to improved cash flow generation Average Annual NAL Production Capacity Long-term value creation rsonal use only Strengthens NAL’s position as a Average LOM SC5.4 (post expansion)

  26. Slide 26: Near-Term Lithium Market Weakness

    Near-Term Lithium Market Weakness Declines in Chinese lithium carbonate futures have pulled prices lower contrary to falling inventories rsonal use only Lithium price weakness appears Spodumene Concentrate 6% Price GFEX Lithium Carbonate Futures driven by sentiment US$/t, CIF China January 2027 Lith

  27. Slide 27: Supportive Demand Outlook into 2030

    Supportive Demand Outlook into 2030 Demand growth presents opportunity for development projects rsonal use only Medium-term demand outlook Broker Outlook Global Lithium Demand remains strong Spodumene Concentrate 6% Price, US$/t Mt LCE $2,400 4.0 • Lithium demand is forecast to approximately double

  28. Slide 28: FY27 Guidance

    FY27 Guidance rsonal use only FY26 Actual FY27 Guidance Additional Information Spodumene 197,967 198,000 – 210,000 • SC 5.2% product grade Concentrate dmt dmt • 100% NAL production Production Spodumene • SC 5.2% product grade 181,494 200,000 – 230,000 Concentrate • Volumes modestly front-weighted (5

  29. Slide 29: Questions?

    rsonal use only 05 Questions?

  30. Slide 30: Thank You for Attending

    Thank You for rsonal use only Attending

  31. Slide 31: Appendix

    rsonal use only Appendix

  32. Slide 32: Supporting Data: Lithium Market Outlook

    Supporting Data Lithium Market Outlook rsonal use only Spodumene Concentrate Est. Global Lithium Demand Est. 2026 2027 2028 2029 2030 2026 2027 2028 2029 2030 6% Price (US$/t) Date (kt LCE) Date Broker 1 Oct-26 2,012 2,043 2,048 1,785 1,680 Broker 1 Oct-26 2,108 2,324 2,510 2,634 2,750 Broker 2 Oct-

Elevra Lithium — Shareholder Meeting (November 2026) on 6ix